Nurix Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $311k | 21k | 14.70 |
| 2023-12-31 | $198k | 19k | 10.32 |
| 2023-09-30 | $268k | 34k | 7.86 |
| 2023-06-30 | $400k | 40k | 9.99 |
| 2022-12-31 | $19k | 1.7k | 10.98 |
| 2022-09-30 | $26k | 2.6k | 9.80 |
| 2022-06-30 | $39k | 3.0k | 13.01 |
| 2022-03-31 | $150k | 11k | 14.00 |
| 2021-12-31 | $607k | 21k | 28.96 |
| 2021-09-30 | $437k | 15k | 30.00 |
| 2021-06-30 | $16k | 320 | 50.00 |
| 2021-03-31 | $430k | 14k | 31.13 |
| 2020-12-31 | $1.6M | 48k | 32.88 |
| 2020-09-30 | $1.2M | 35k | 34.90 |